APPLICATION
ANDA208705
TYPE
ANDA
ORIGINAL APPROVAL
2017-05-12
LATEST ACTION
2026-03-11
ROUTE
ORAL
DOSAGE FORM
CAPSULE, DELAYED RELEASE
MARKETING STATUS
Prescription
Products
FENOFIBRIC ACIDPrescription
CHOLINE FENOFIBRATE EQ 45MG FENOFIBRIC ACID · CAPSULE, DELAYED RELEASE · ORAL
FENOFIBRIC ACIDPrescription
CHOLINE FENOFIBRATE EQ 135MG FENOFIBRIC ACID · CAPSULE, DELAYED RELEASE · ORAL
Approval history
2026-03-11Labeling · Supplement 22 · standardAP
2026-03-11Labeling · Supplement 29 · standardAP
2019-09-19Labeling · Supplement 9 · standardAP
2019-09-19Labeling · Supplement 7 · standardAP
2019-09-19Labeling · Supplement 11 · standardAP
2017-05-12UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.